New clues about irritable bowel syndrome found in the brain
Breakthrough research led by Addenbrooke's Hospital gives IBS patients like Laura Tebbs a better understanding of their condition.
Irritable bowel syndrome (IBS) is a common condition world-wide, affecting around one in 10 people and causing a wide range of symptoms including abdominal pain, bloating and bowel dysfunction.
The study involved over 40 institutions and looked at genetic data from more than 50,000 people with IBS and compared it to more than 400,000 people without the condition.
It found that people at greater risk of IBS were also at greater risk for common mood disorders, such as anxiety, depression, neuroticism and insomnia.
However, researchers stress this doesn’t mean anxiety causes IBS symptoms or vice versa.
For more information visit: CUH News
Published September 5 2021
Latest from CCTU
National Patient Led Research Hub celebrates tenth anniversary
A national team based in Cambridge are celebrating ten years of helping people living with rare diseases to develop their own research ideas. The hub has…
Hope for MS patients as Cambridge trial suggests drug combination may repair nerve damage
Early findings from a clinical trial in Cambridge suggest a combination of metformin, a diabetes drug, and clemastine, an antihistamine, can help repair…
Prospective study into controversial brain cyst syndrome is world first
The world’s first study of its kind highlights the potential value of surgery to treat a specific kind of brain cyst that blights the lives of patients.
